Reference number : 236-2013-2014-Q1-00122, amendment number : , agreement type : G, recipient legal name : FELD, Jordan J, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 573786.0, agreement start date : 2013-10-01, agreement end date : 2016-09-30, description english : Randomized controlled trial of the efficacy of pre-emptive tenofovir to prevent hepatitis B reactivation in patients who are anti-HBc antibody positive receiving curative intent rituximab-based chemotherapy for non-Hodgkin's lympohma, description french : Randomized controlled trial of the efficacy of pre-emptive tenofovir to prevent hepatitis B reactivation in patients who are anti-HBc antibody positive receiving curative intent rituximab-based chemotherapy for non-Hodgkin's lympohma, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2013-14 to 2016-17), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2013-14 à 2016-17), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada